In a recent development, Gordon Rees Scully Mansukhani (GRSM) has announced the return of Jeffrey Lilly to their Austin office, where he takes on the role of a litigation partner. Lilly, known for his extensive experience in handling complex litigation matters, previously worked with GRSM before exploring other opportunities.
Lilly’s areas of expertise are broad and encompass pharmaceutical and medical device litigation, product liability, construction defect, environmental and toxic tort, and professional liability. He has represented a diverse client base, including Fortune 500 companies, smaller enterprises, and individuals. His practice frequently involves litigation in both state and federal courts across Texas and the United States, with a particular focus on national multidistrict litigation.
The move is seen as a strategic boon for GRSM as they reinforce their litigation capabilities in the Austin market. According to the firm, Lilly’s return will bolster their service offerings to existing clients and attract new business, reinforcing the firm’s standing in high-stakes litigation.
This announcement follows a pattern of law firms leveraging the expertise of seasoned litigators to expand their reach and dominance in specialized legal sectors. For those involved in legal practice areas connected to Lilly’s expertise, this appointment may signal increased activity and competition within the Austin litigation landscape.
For further details on Jeffrey Lilly’s appointment and its implications, visit Bloomberg Law’s report
.